tralokinumab

Brainomix AI shows its worth in AZ pulmonary fibrosis trial
Pharmaphorum
Wed, 03/27/24 - 10:55 am
AstraZeneca
Brainomix
tralokinumab
IPF
artificial intelligence
Leo puts target on Dupixent in US as FDA clears tralokinumab
Pharmaforum
Thu, 12/30/21 - 10:45 am
Sanofi
Regeneron
Dupixent
tralokinumab
FDA
LEO eyeing 2021 US launch for eczema drug tralokinumab
Pharmaforum
Fri, 07/10/20 - 10:47 am
LEO Pharma
eczema
tralokinumab
Sanofi
Dupixent
AAD 2020 – Leo’s eczema wildcard proves tame
EP Vantage
Fri, 06/12/20 - 08:02 pm
LEO Pharma
Sanofi
Regeneron
eczema
atopic dermatitis
AAD
tralokinumab
Leo's Dupixent rival hits all endpoints in pivotal program
Fierce Biotech
Wed, 12/11/19 - 10:36 am
LEO Pharma
atopic dermatitis
tralokinumab
Sanofi
Regeneron
Dupixent
AstraZeneca sweeps out a PhIII asthma flop, a PD-1 drug and some other rejects as Q4 tally disappoints
Endpoints
Fri, 02/2/18 - 09:18 am
AstraZeneca
PD-1 inhibitors
asthma
tralokinumab
lebrikizumab
AstraZeneca asthma drug tralokinumab disappoints again
Yahoo/Reuters
Wed, 11/1/17 - 09:37 am
AstraZeneca
tralokinumab
severe asthma
AstraZeneca’s PhIII bid on asthma drug tralokinumab flops, and that’s no surprise
Endpoints
Wed, 05/10/17 - 09:38 am
AstraZeneca
asthma
tralokinumab
clinical trials
AstraZeneca starts final-stage tests on severe asthma drug
Yahoo/Reuters
Thu, 08/14/14 - 08:17 am
asthma
AstraZeneca
tralokinumab